A phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer

被引：0

作者：

Oaknin, A. ^{[1
]}

Rubio Perez, M. J. ^{[2
]}

Farinas Madrid, L. ^{[3
]}

Redondo, A. ^{[4
]}

Yubero Esteban, A. ^{[5
]}

Gil Martin, M. ^{[6
]}

Gonzalez Martin, A. ^{[7
]}

Romero, I. ^{[8
]}

Garcia-Donas, J. ^{[9
,10
]}

Serrano, R. ^{[11
]}

Gallego Martinez, A. ^{[12
]}

Ocariz Diez, M. ^{[13
]}

Sanchez Lorenzo, M. L. ^{[14
]}

Lopez Olmedo, M. D. Fenor De La Maza ^{[15
]}

Rodriguez Freixinos, V. ^{[3
]}

Piulats Rodriguez, J. M. ^{[16
]}

机构：

[1] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain

[2] Reina Sofia Univ Hosp, Dept Med Oncol, Cordoba, Spain

[3] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

[4] Hosp Univ La Paz, Oncol Med, Madrid, Spain

[5] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain

[6] Hosp Duran & Reynals, ICO, Dept Med Oncol, Lhospitalet De Llobregat, Spain

[7] Clin Univ Navarra, Dept Med Oncol, Madrid, Spain

[8] IVO Fdn Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain

[9] Hosp Madrid Norte San Chinarro, Genitourinary Ginecologycal Skin & Rare Tumours U, Madrid, Spain

[10] Ctr Integral Oncol Clara Campal, Madrid, Spain

[11] Hosp Univ Reina Sofia, Dept Med Oncol, Cordoba, Spain

[12] Hosp Univ La Paz, Med Oncol, Madrid, Spain

[13] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain

[14] Clin Univ Navarra, Med Oncol, Madrid, Spain

[15] Clara Campal Comprehens Canc Ctr, Med Oncol, Madrid, Spain

[16] Hosp Duran & Reynals, ICO Inst Catala Oncol Hosp, Dept Med Oncol, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1062TiP

引用

页数：2